Clearmind Medicine Inc. (CMND)

NASDAQ: CMND · IEX Real-Time Price · USD

1.255

-0.005 (-0.40%)

At close: Apr 15, 2024, 12:00 AM

1.230

-0.025 (-1.99%)

Pre-market: Apr 16, 2024, 8:39 AM EDT

Clearmind Medicine Income Statement

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Year	2023	2022	2021	2020
Selling, General & Admin	4.76	3.17	2.22	0.23
Research & Development	1.54	3.08	0.47	0
Operating Expenses	6.3	6.25	2.69	0.23
Operating Income	-6.3	-6.25	-2.69	-0.23
Other Expense / Income	2.3	0.61	0.03	0.18
Pretax Income	-8.6	-6.87	-2.73	-0.41
Income Tax	0.02	0.03	0	0
Net Income	-8.62	-6.89	-2.73	-0.41
Shares Outstanding (Basic)	0	0	0	0
Shares Outstanding (Diluted)	0	0	0	0
Shares Change	367.25%	40.19%	70.50%	-
EPS (Basic)	-42.58	-159.11	-88.16	-22.80
EPS (Diluted)	-42.58	-159.11	-88.16	-22.80
Free Cash Flow	-6.3	-3.73	-2.1	-0.27
Free Cash Flow Per Share	-31.12	-86.08	-67.98	-15.14
EBITDA	-8.55	-6.78	-2.72	-0.41
Depreciation & Amortization	0.06	0.08	0	0
EBIT	-8.6	-6.87	-2.73	-0.41

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).